Lv2
144 积分 2021-10-18 加入
Prostate Cancer–related Events in Patients with Synchronous Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate; Data from the HORRAD Trial
28天前
已完结
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
28天前
已完结
Based on ARASENS trial: efficacy and safety of darolutamide as an emerging option of endocrinotherapy for metastatic hormone-sensitive prostate cancer—an updated systematic review and network meta-analysis
3个月前
已完结
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
4个月前
已完结
Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer
4个月前
已完结
Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study
5个月前
已完结
Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease
5个月前
已完结
Changing Nature of High Risk Patients Undergoing Radical Prostatectomy
7个月前
已完结
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
8个月前
已完结
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
8个月前
已完结
皖公网安备34019202002308
